» Articles » PMID: 38017530

Breaking Barriers: Exploring Mechanisms Behind Opening the Blood-brain Barrier

Overview
Publisher Biomed Central
Date 2023 Nov 29
PMID 38017530
Authors
Affiliations
Soon will be listed here.
Abstract

The blood-brain barrier (BBB) is a selectively permeable membrane that separates the bloodstream from the brain. While useful for protecting neural tissue from harmful substances, brain-related diseases are difficult to treat due to this barrier, as it also limits the efficacy of drug delivery. To address this, promising new approaches for enhancing drug delivery are based on disrupting the BBB using physical means, including optical/photothermal therapy, electrical stimulation, and acoustic/mechanical stimulation. These physical mechanisms can temporarily and locally open the BBB, allowing drugs and other substances to enter. Focused ultrasound is particularly promising, with the ability to focus energies to targeted, deep-brain regions. In this review, we examine recent advances in physical approaches for temporary BBB disruption, describing their underlying mechanisms as well as evaluating the utility of these physical approaches with regard to their potential risks and limitations. While these methods have demonstrated efficacy in disrupting the BBB, their safety, comparative efficacy, and practicality for clinical use remain an ongoing topic of research.

Citing Articles

The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


Regulation of Vascular Injury and Repair by P21-Activated Kinase 1 and P21-Activated Kinase 2: Therapeutic Potential and Challenges.

Han C, Zhu M, Liu Y, Yang Y, Cheng J, Li P Biomolecules. 2025; 14(12.

PMID: 39766303 PMC: 11674331. DOI: 10.3390/biom14121596.


A comprehensive neuroimaging review of the primary and metastatic brain tumors treated with immunotherapy: current status, and the application of advanced imaging approaches and artificial intelligence.

Liu X, Chen H, Tan G, Zhong L, Jiang H, Smith S Front Immunol. 2024; 15():1496627.

PMID: 39669560 PMC: 11634813. DOI: 10.3389/fimmu.2024.1496627.


Scientific issues with rodent models of neuromyelitis optic spectrum disorders.

Huang Y, Wang T, Wang F, Wu Y, Ai J, Zhang Y Front Immunol. 2024; 15:1423107.

PMID: 39628487 PMC: 11611858. DOI: 10.3389/fimmu.2024.1423107.


Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier.

Cazalla E, Cuadrado A, Garcia-Yague A Fluids Barriers CNS. 2024; 21(1):93.

PMID: 39574123 PMC: 11580557. DOI: 10.1186/s12987-024-00599-5.


References
1.
Wolburg H, Lippoldt A . Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol. 2003; 38(6):323-37. DOI: 10.1016/s1537-1891(02)00200-8. View

2.
Gray M, Woulfe J . Striatal blood-brain barrier permeability in Parkinson's disease. J Cereb Blood Flow Metab. 2015; 35(5):747-50. PMC: 4420870. DOI: 10.1038/jcbfm.2015.32. View

3.
Seteikin A, Krasnikov I, Drakaki E, Makropoulou M . Dynamic model of thermal reaction of biological tissues to laser-induced fluorescence and photodynamic therapy. J Biomed Opt. 2013; 18(7):075002. DOI: 10.1117/1.JBO.18.7.075002. View

4.
He Q, Liu J, Liang J, Liu X, Li W, Liu Z . Towards Improvements for Penetrating the Blood-Brain Barrier-Recent Progress from a Material and Pharmaceutical Perspective. Cells. 2018; 7(4). PMC: 5946101. DOI: 10.3390/cells7040024. View

5.
Cancel L, Arias K, Bikson M, Tarbell J . Direct current stimulation of endothelial monolayers induces a transient and reversible increase in transport due to the electroosmotic effect. Sci Rep. 2018; 8(1):9265. PMC: 6006334. DOI: 10.1038/s41598-018-27524-9. View